Xi Jiang

Xi Jiang

Auto-generated profile, based on publicly available information

Xi Jiang

Department of Clinical Laboratory, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Diabetes Research
Verified
Journal Article
Open access
ZZZhen Zhang
Zhen Zhang
XJXi Jiang
Xi Jiang
LZLi Zhang
Li Zhang
YFYing Feng
Ying Feng
JTJiahao Tang
Jiahao Tang
FLFangping Li
Fangping Li
Aims: This mediation analysis was aimed at examining whether ghrelin mediates the association between gut microbiota and glucose metabolic indices. Materials and Methods: Fifty‐five patients with newly diagnosed Type 2 diabetes mellitus (T2DM) and 40 healthy controls (HCs) were included. Serum ghrelin levels were measured by ELISA. Fecal 16S rRNA gene sequencing was performed, and gut microbiota differences were assessed using linear discriminant analysis effect size (LEfSe). The relative abundance values of differential bacteria were extracted to correlate with ghrelin and glucose metabolic indices. Mediation analysis was conducted to evaluate ghrelin’s effect on the relationship between bacterial abundance and glucose metabolic indices. Results: Acylated ghrelin (AG) levels were significantly elevated in the T2DM group and showed positive correlations with glycated hemoglobin (HbA1c), fasting blood glucose (FBG), C‐peptide (CP), and homeostasis model assessment of insulin resistance (HOMA‐IR). Microbial analysis revealed decreased abundances of Akkermansia , Lachnospira , and Phocaeicola , but increased abundances of Enterobacter , Escherichia , Megamonas , Segatella , Streptococcus , and Leyella in T2DM. AG levels were negatively correlated with Akkermansia abundance. HbA1c and FBG showed positive correlations with Enterobacter , Segatella , and Leyella abundances, but negative correlations with Akkermansia , Lachnospira , and Phocaeicola abundances. HOMA‐IR was positively correlated with Segatella , Leyella , and Streptococcus abundances, but negatively correlated with Akkermansia and Lachnospira abundances. Mediation analysis demonstrated that serum AG partially mediated the association between Akkermansia abundance and both HOMA‐IR (26.15%) and HbA1c (27.91%). Conclusions: AG mediated the relationship between Akkermansia abundance and HOMA‐IR as well as HbA1c.

1 December 2025 in Infection and Drug Resistance
Verified
Journal Article
Open access
MLMengna Liu
Mengna Liu
XJXi Jiang
Xi Jiang
YPYingqi Pi
Yingqi Pi
XRXiuqin Ren
Xiuqin Ren
MCMingming Chen
Mingming Chen
XXXiaoying Xie
Xiaoying Xie
Background: Agrobacterium radiobacter (A. radiobacter) is a gram-negative environmental bacterium primarily found in soil and plants. While it exhibits low virulence, it can act as an opportunistic pathogen in immunocompromised hosts. Its variable antibiotic resistance patterns pose challenges in clinical management. In this context, we reported a case of catheter-related bloodstream infection (CRBSI) caused by A. radiobacter and reviewed its clinical features, diagnostic challenges, and treatment strategies. Case Presentation: A 70-year-old male with stage IIIA gastric adenocarcinoma and a chemotherapy-associated central venous catheter (CVC) presented with fever and elevated procalcitonin (3.02 ng/mL). Blood cultures from CVC and periphery grew A. radiobacter. Empirical piperacillin/tazobactam transiently improved symptoms, but recurrent fever prompted CVC removal on day 10 of hospitalization, leading to rapid resolution of fever, normalization of procalcitonin, and negative follow-up blood cultures. Conclusion: This case highlights the critical role of catheter removal and susceptibility-guided antibiotic therapy for A. radiobacter infections in immunocompromised patients, addressing biofilm challenges and informing antimicrobial stewardship. Collaborative research integrating microbiology, genomics, and clinical data is essential to refine treatment algorithms and improve outcomes in immunocompromised hosts.